MARY LARACH: Open Payments
NPI 1013942762 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,291 in 11 payments from 9 companies in 2025. Trend: 2023 $1,269 · 2024 $773 · 2025 $1,291
Food & beverage: $1,291
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $254 |
| Madrigal Pharmaceuticals | 2 | $238 |
| Novo Nordisk Inc | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Genentech USA, Inc. | 1 | $122 |
| Medtronic, Inc. | 1 | $111 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $100 |
| Corcept Therapeutics | 1 | $96 |
Products named: REZDIFFRA, ULTOMIRIS, Wegovy, Kerendia, REXULTI, Xolair, INCEPTIV, NEFFY.
Industry payments across NC — which companies pay providers there.
